Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 36, Iss 5-6, Pp 133-147 (2013)
Analytical Cellular Pathology, Vol 36, Iss 5-6, Pp 133-147 (2013)
Background and ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products.Methods: Immunohistoch
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 35, Iss 5-6, Pp 381-393 (2012)
Analytical Cellular Pathology, Vol 36, Iss 1-2, Pp 61-62 (2013)
Analytical Cellular Pathology, Vol 35, Iss 5-6, Pp 381-393 (2012)
Analytical Cellular Pathology, Vol 36, Iss 1-2, Pp 61-62 (2013)
Whole-slide imaging of tissue microarrays (TMAs) holds the promise of automated image analysis of a large number of histopathological samples from a single slide. This demands high-throughput image processing to enable analysis of these tissue sample
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 35, Iss 5-6, Pp 339-361 (2012)
Analytical Cellular Pathology, Vol 35, Iss 5-6, Pp 339-361 (2012)
Spectral imaging methods are attracting increased interest from researchers and practitioners in basic science, pre-clinical and clinical arenas. A combination of better labeling reagents and better optics creates opportunities to detect and measure
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 35, Iss 1, Pp 11-18 (2012)
Analytical Cellular Pathology, Vol 35, Iss 1, Pp 11-18 (2012)
Background: The aim of the Eastern Québec telepathology project is to provide uniform diagnostic telepathology services across a huge geographic region with a low population density. This project is intended to provide surgeons and pathologists with
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 34, Iss 5, Pp 235-246 (2011)
Analytical Cellular Pathology, Vol 34, Iss 5, Pp 235-246 (2011)
Hematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. As these tissues are naturally connected through the immune system, a disease affecting one of them will often affect the others as well. The hematolog
Autor:
Bruno F. Fernandes, Sebastian Di Cesare, Rubens Neto Belfort, Shawn Maloney, Claudia Martins, Enzo Castiglione, Jordan Isenberg, Daniel Abourbih, Emilia Antecka, Miguel N. Burnier Jr.
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Analytical Cellular Pathology, Vol 34, Iss 3, Pp 123-130 (2011)
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Analytical Cellular Pathology, Vol 34, Iss 3, Pp 123-130 (2011)
Imatinib mesylate (IM) is a compound that inhibits both BCR-ABL tyrosine kinase and c-kit receptors. Tyrosine kinases are important in cellular signaling and mediate major cellular processes such as proliferation, differentiation, apoptosis, attachme
Autor:
Sylvia Timme, Eberhard Schmitt, Stefan Stein, Jutta Schwarz-Finsterle, Jenny Wagner, Axel Walch, Martin Werner, Michael Hausmann, Thorsten Wiech
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 34, Iss 1-2, Pp 21-33 (2011)
Analytical Cellular Pathology, Vol 34, Iss 1-2, Pp 21-33 (2011)
Cell type specific radial positioning of chromosome territories (CTs) and their sub-domains in the interphase seem to have functional relevance in non-neoplastic human nuclei, while much less is known about nuclear architecture in carcinoma cells and
Autor:
Vassiliki Pelekanou, George Notas, Katerina Theodoropoulou, Marilena Kampa, Dimitrios Takos, Vassilia-Ismini Alexaki, Jelena Radojicic, Frank Sofras, Andreas Tsapis, Efstathios N. Stathopoulos, Elias Castanas
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 34, Iss 1-2, Pp 49-60 (2011)
Analytical Cellular Pathology, Vol 34, Iss 1-2, Pp 49-60 (2011)
In advanced renal cell carcinoma (RCC), surgery combined with systemic chemotherapy and immunotherapy have had limited effectiveness. Therapeutic modalities targeting VEGF, PDGF, and c-kit using tyrosine kinase inhibitors and m-TOR using specific bio